Oscar has led AI strategic initiatives and product development across Fortune 50 (
Johnson & Johnson) and VC-backed biotech (
PathAI) companies, bringing a unique lens into the rapidly changing ecosystem of AI for life sciences. Oscar has expertise in AI product strategy, pharma-tech partnering, AI startup diligence, and validation and regulatory strategies.
Oscar is also passionate about startups and participating in Accelerators and Incubators within the Cambridge / Boston community.
Oscar holds a PhD in Biomedical Engineering and has conducted AI research in industry and academia, including at MIT and Duke. Collectively, Oscar’s research has produced 130+ articles and presentations in top-tier journals (eg Nature Medicine, Nature Comms) as well as technical and clinical conferences. Oscar’s experience includes AI/ML (computer vision, generative AI, foundational models) in biopharma R&D and diagnostics across multiple diseases (ONC, IMM, CVM, ophthalmology).
